SEC Form 4 · accession 0001055726-19-000013
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B. Weiner
Director
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 9, 2019 | M | 5,333 | — | A | 783,625 | D | |
| Common StockF2 | Mar 9, 2019 | M | 10,000 | — | A | 793,625 | D | |
| Common StockF3 | Mar 10, 2019 | M | 11,667 | — | A | 805,292 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1 | — | Mar 9, 2019 | M | 5,333 | D | — | — | Common Stock | 5,333 | 0 | D |
| Restricted Stock UnitF2 | — | Mar 9, 2019 | M | 10,000 | D | — | — | Common Stock | 10,000 | 0 | D |
| Restricted Stock UnitF3 | — | Mar 10, 2019 | M | 11,667 | D | — | — | Common Stock | 11,667 | 11,666 | D |
| Common Stock OptionF4 | $3.34 | Mar 8, 2019 | A | 60,000 | A | Mar 8, 2019 | Mar 8, 2029 | Common Stock | 60,000 | 60,000 | D |
| Restricted Stock UnitF5 | — | Mar 8, 2019 | A | 35,000 | A | — | — | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,000 restricted stock units was as follows: 5,334 shares vested on March 9, 2017; 5,333 shares vested on March 9, 2018; 5,333 shares vested on March 9, 2019.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 30,000 restricted stock units is as follows: 10,000 shares vested on March 9, 2017; 10,000 shares vested on March 9, 2018; 10,000 shares vested on March 9, 2019.
- F3Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- F4The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on March 8, 2019; 15,000 shares will vest on March 8, 2020; 15,000 shares will vest on March 8, 2021; 15,000 shares will vest on March 8, 2022.
- F5Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.